Issue 6, 2015

Targeted metabolomics in the expanded newborn screening for inborn errors of metabolism

Abstract

Inborn errors of metabolism are genetic disorders due to impaired activity of enzymes, transporters, or cofactors resulting in accumulation of abnormal metabolites proximal to the metabolic block, lack of essential products or accumulation of by-products. Many of these disorders have serious clinical consequences for affected neonates, and an early diagnosis allows presymptomatic treatment which can prevent severe permanent sequelae and in some cases death. Expanded newborn screening for these diseases is a promising field of targeted metabolomics. Here we report the application, between 2007 and 2014, of this approach to the identification of newborns in southern Italy at risk of developing a potentially fatal disease. The analysis of amino acids and acylcarnitines in dried blood spots by tandem mass spectrometry revealed 24 affected newborns among 45 466 infants evaluated between 48 and 72 hours of life (overall incidence: 1 : 1894). Diagnoses of newborns with elevated metabolites were confirmed by gas chromatography-mass spectrometry, biochemical studies, and genetic analysis. Five infants were diagnosed with medium-chain acyl CoA dehydrogenase deficiency, 1 with methylmalonic acidemia with homocystinuria type CblC, 2 with isolated methylmalonic acidemia, 1 with propionic acidemia, 1 with isovaleric academia, 1 with isobutyryl-CoA dehydrogenase deficiency, 1 with beta ketothiolase deficiency, 1 with short branched chain amino acid deficiency, 1 with 3-methlycrotonyl-CoA carboxylase deficiency, 1 with formimino-transferase cyclodeaminase deficiency, and 1 with cystathionine-beta-synthase deficiency. Seven cases of maternal vitamin B12 deficiency and 1 case of maternal carnitine uptake deficiency were detected. This study supports the widespread application of metabolomic-based newborn screening for these genetic diseases.

Graphical abstract: Targeted metabolomics in the expanded newborn screening for inborn errors of metabolism

  • This article is part of the themed collection: Proteomics

Supplementary files

Article information

Article type
Paper
Submitted
19 12 2014
Accepted
06 2 2015
First published
06 2 2015

Mol. BioSyst., 2015,11, 1525-1535

Targeted metabolomics in the expanded newborn screening for inborn errors of metabolism

E. Scolamiero, C. Cozzolino, L. Albano, A. Ansalone, M. Caterino, G. Corbo, M. G. di Girolamo, C. Di Stefano, A. Durante, G. Franzese, I. Franzese, G. Gallo, P. Giliberti, L. Ingenito, G. Ippolito, B. Malamisura, P. Mazzeo, A. Norma, D. Ombrone, G. Parenti, S. Pellecchia, R. Pecce, I. Pierucci, R. Romanelli, A. Rossi, M. Siano, T. Stoduto, G. R. D. Villani, G. Andria, F. Salvatore, G. Frisso and M. Ruoppolo, Mol. BioSyst., 2015, 11, 1525 DOI: 10.1039/C4MB00729H

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Spotlight

Advertisements